Join Now

Author Archives: Natalie Themm

Inherent Biosciences and Genomic Prediction Announce Commercial Partnership to Advance Male Reproductive Health

By Natalie Themm | Published February 1, 2024

Inherent Biosciences and Genomic Prediction Announce Commercial Partnership to Advance Male Reproductive Health

Posted in BioUtah News | Tagged | Comments Off on Inherent Biosciences and Genomic Prediction Announce Commercial Partnership to Advance Male Reproductive Health

Utah Innovation Fund invests $700k in local healthcare, life sciences startups

By Natalie Themm | Published February 1, 2024

Utah Innovation Fund invests $700k in local healthcare, life sciences startups

Posted in BioUtah News | Tagged | Comments Off on Utah Innovation Fund invests $700k in local healthcare, life sciences startups

BD, Techcyte Announce Strategic Collaboration to Offer AI-Based Digital Cervical Cytology System for Pap Testing

By Natalie Themm | Published February 1, 2024

AI-Based Algorithm Aims to Enable Cytotechnologists and Pathologists to Efficiently Identify Evidence of Cervical Cancer and Precancerous Lesions

Posted in BioUtah News | Tagged | Comments Off on BD, Techcyte Announce Strategic Collaboration to Offer AI-Based Digital Cervical Cytology System for Pap Testing

Myriad Genetics Names George Daneker Jr., MD, as President and Chief Clinical Officer of Oncology

By Natalie Themm | Published February 1, 2024

SALT LAKE CITY, Jan. 30, 2024 (GLOBE NEWSWIRE) — Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced the appointment of George Daneker Jr., MD, as President and Chief Clinical Officer of Oncology, effective March 18, 2024. Dr. Daneker brings more than 30 years of oncology and precision medicine […]

Posted in BioUtah News | Tagged | Comments Off on Myriad Genetics Names George Daneker Jr., MD, as President and Chief Clinical Officer of Oncology

bioMérieux announces nomination of two new Executive Committee members to lead Medical Affairs and R&D

By Natalie Themm | Published February 1, 2024

bioMérieux announces nomination of two new Executive Committee members to lead Medical Affairs and R&D

Posted in BioUtah News | Tagged | Comments Off on bioMérieux announces nomination of two new Executive Committee members to lead Medical Affairs and R&D

Constant Therapeutics Announces First Patient Dosed in Phase 2 Clinical Trial of TXA127 in Ischemic Stroke Recovery

By Natalie Themm | Published February 1, 2024

Constant Therapeutics Announces First Patient Dosed in Phase 2 Clinical Trial of TXA127 in Ischemic Stroke Recovery

Posted in BioUtah News | Tagged | Comments Off on Constant Therapeutics Announces First Patient Dosed in Phase 2 Clinical Trial of TXA127 in Ischemic Stroke Recovery

ATL Technology: MD&M West 2024: Tech Talk and Meeting Registration

By Natalie Themm | Published January 25, 2024

ATL Technology: MD&M West 2024: Tech Talk and Meeting Registration

Posted in BioUtah News | Tagged | Comments Off on ATL Technology: MD&M West 2024: Tech Talk and Meeting Registration

ARUP’s Julio Delgado, MD, MS, Selected as Inaugural Harry R. Hill, MD, Presidential Endowed Chair-Holder

By Natalie Themm | Published January 25, 2024

ARUP’s Julio Delgado, MD, MS, Selected as Inaugural Harry R. Hill, MD, Presidential Endowed Chair-Holder

Posted in BioUtah News | Tagged | Comments Off on ARUP’s Julio Delgado, MD, MS, Selected as Inaugural Harry R. Hill, MD, Presidential Endowed Chair-Holder

Thermo Fisher Scientific Receives GMP approval from the Italian Medicines Agency (AIFA) for its Manufacturing facility of RNA-Based Products in Monza, Italy

By Natalie Themm | Published January 25, 2024

GMP certification helps enable biotechnology customers to accelerate accessibility of new RNA-based therapies for patients.

Posted in BioUtah News | Tagged | Comments Off on Thermo Fisher Scientific Receives GMP approval from the Italian Medicines Agency (AIFA) for its Manufacturing facility of RNA-Based Products in Monza, Italy

BD Helps Advance Health Equity for Women in Kenya through Critical Cancer Screening

By Natalie Themm | Published January 25, 2024

Collaboration with Kenya Ministry of Health National Cancer Institute Aims to Expand Access to Diagnostics, Reduce Cervical Cancer Rates

Posted in BioUtah News | Tagged | Comments Off on BD Helps Advance Health Equity for Women in Kenya through Critical Cancer Screening

NUSANO NAMES ROHAN JAIN AS COMMERCIAL GENERAL MANAGER

By Natalie Themm | Published January 25, 2024

Nusano Names Rohan Jain as Commercial General Manager.

Posted in BioUtah News | Tagged | Comments Off on NUSANO NAMES ROHAN JAIN AS COMMERCIAL GENERAL MANAGER

Thermo Fisher Scientific Unveils Industry’s First Off-the-Shelf Validated Software Solution to Automate Cell Therapy Manufacturing Workflows

By Natalie Themm | Published January 18, 2024

Gibco CTS Cellmation Software digitally connects instruments from across Thermo Fisher’s cell therapy portfolio to streamline and automate manufacturing

Posted in BioUtah News | Tagged | Comments Off on Thermo Fisher Scientific Unveils Industry’s First Off-the-Shelf Validated Software Solution to Automate Cell Therapy Manufacturing Workflows

A Special Thanks To Our Legacy and Platinum Elite Members